Home

JAY T FLATLEY

CIK 1189130 · Chairman and Acting CEO · last filed 2026-06-23

JAY T FLATLEY is a Chairman and Acting CEO who has filed 354 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for RIVN, was dated Jun 23, 2026. Across all open-market trades the lifetime net is −$492.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $42.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$42.24M

Companies

6

Total Filings

354

Lifetime Open-Market Net

-$491.98M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RIVN Director 179,515 $16.57 $2.97M $2.75M 8 2026-06-23
DNLI Director 358,941 $24.16 $8.67M $0 12 2026-06-05
Zymergen Inc. (ZY) Delisted Chairman and Acting CEO 0 $2.43 $0 $1.00M 4 2022-10-19
COHR Director 856 $246.41 $210.9K -$2.07M 22 2022-07-01
ILMN Director 152,433 $199.35 $30.39M -$494.38M 303 2021-05-20
Juno Therapeutics, Inc. (JUNO) Delisted Director 0 — — $724.4K 5 2018-03-07

Recent Filings

354 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-23 RIVN Grant (A) +17,445 $0 EDGAR
2026-06-05 DNLI Grant (A) +6,408 $0 EDGAR
2026-03-05 RIVN Mixed +1,250 $13.5K EDGAR
2025-06-20 RIVN Grant (A) +16,812 $0 EDGAR
2025-06-05 DNLI Grant (A) +6,037 $0 EDGAR
2024-06-21 RIVN Grant (A) +24,224 $0 EDGAR
2024-06-04 DNLI Grant (A) +5,967 $0 EDGAR
2023-06-23 RIVN Grant (A) +18,208 $0 EDGAR
2023-06-05 DNLI Grant (A) +4,216 $0 EDGAR
2022-10-19 Zymergen Inc. (ZY) Delisted Disp (D) −144,789 $0 EDGAR
Showing 1–10 of 354
Page 1 of 36
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.